Skip to main content
. 2015 Aug 18;10:5205–5218. doi: 10.2147/IJN.S84326

Table 1.

Characterization of the prepared SH-ASA/Cur nanoparticles

Sample Solvent Drug: polymera EEA (%) EEC (%) Size (nm) PDI DLA (%) DLC (%) Stability
S1 Chloroform 1:20 80±3.12 92.76±4.56 387.6±31.3 0.418±0.047 3.09±0.08 0.93±0.01 2 hours
S2 Dichloromethane 1:20 92.65±4.26 90.84±4.23 284±18.6 0.286±0.028 3.51±0.06 0.90±0.02 24 hours
S3 Ethyl acetate 1:20 83.17±3.04 87.3±3.68 122.3±6.8 0.179±0.016 3.15±0.05 0.88±0.05 72 hours
S4 Ethyl acetate 1:5 35.06±2.76 40.74±2.45 271.6±13.6 0.402±0.02 5.12±0.13 1.65±0.11 <10 minutes
S5 Ethyl acetate 1:10 70.82±4.43 79.71±5.88 172.2±8.8 0.276±0.012 5.38±0.14 1.53±0.09 4 hours
S7 Ethyl acetate 1:30 89.56±3.56 94.12±3.14 107.1±2.3 0.171±0.016 2.21±0.05 0.74±0.02 >96 hours

Notes:

a

In feed; Data is presented as mean ± standard deviation.

Abbreviations: SH-ASA, SH-aspirin; Cur, curcumin; EEA, entrapment efficiency of aspirin; EEC, entrapment efficiency of curcumin; PDI, polydispersity index; DLA, drug-loading efficiency of aspirin; DLC, drug-loading efficiency of curcumin.